Literature DB >> 28885902

Measuring both serum amylase and lipase for acute pancreatitis lowers quality and raises cost.

Abdulhadi Akhtar1, Ravindra Sarode2, Deepak Agrawal3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28885902     DOI： 10.3949/ccjm.84a.16103

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  3 in total

1.  Serum lipase as a biomarker for early prediction and diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Yu Zhang; Xiaoling Ye; Xinyue Wan; Tao Deng
Journal:  Ir J Med Sci       Date:  2019-08-28       Impact factor: 1.568

2.  Audit of amylase and lipase requests in suspected acute pancreatitis and cost implications, South Africa.

Authors:  Annie E Cook; Thumeka P Jalavu; Annalise E Zemlin
Journal:  Afr J Lab Med       Date:  2022-09-26

3.  Superfluous amylase/lipase testing at a tertiary care hospital: a retrospective study.

Authors:  Ahmed S Aljomah; Muhammad M Hammami
Journal:  Ann Saudi Med       Date:  2019-10-03       Impact factor: 1.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.